Meanwhile, the hADMSC-CM and exosomes were shown to increase doxorubicin resistance and tumor cell migration either by increasing breast cancer resistance protein (BCRP) levels or by activating the Wnt signaling pathway in BCCs, respectively [155, 156]. The gene discussed is ABCG2; the disease is neoplasm.